Cost-effectiveness of statins in older adults: further evidence that less is more.
作者信息
Rich Michael W
出版信息
Ann Intern Med. 2015 Apr 21;162(8):590-1. doi: 10.7326/M15-0535.
DOI:10.7326/M15-0535
PMID:25894030
Abstract
摘要
相似文献
1
Cost-effectiveness of statins in older adults: further evidence that less is more.
Ann Intern Med. 2015 Apr 21;162(8):590-1. doi: 10.7326/M15-0535.
2
Statins for primary prevention in older adults.
Ann Intern Med. 2015 Apr 21;162(8):I-28. doi: 10.7326/P15-9012.
3
Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.
Ann Intern Med. 2015 Apr 21;162(8):533-41. doi: 10.7326/M14-1430.
4
Statins for Primary Prevention in Adults Aged 75 Years or Older.
Ann Intern Med. 2015 Sep 15;163(6):481. doi: 10.7326/L15-5135.
5
Statins for Primary Prevention in Adults Aged 75 Years or Older.
Ann Intern Med. 2015 Sep 15;163(6):481. doi: 10.7326/L15-5135-2.
6
Statins for Primary Prevention in Adults Aged 75 Years or Older.
Ann Intern Med. 2015 Sep 15;163(6):482. doi: 10.7326/L15-5135-3.
7
Statins for the primary prevention of cardiovascular disease in women?
Menopause. 2012 Dec;19(12):1287-8. doi: 10.1097/gme.0b013e318273028f.
8
[Statins in primary prevention - a must for the general practitioner?].
Praxis (Bern 1994). 2011 Jul 6;100(14):859-60. doi: 10.1024/1661-8157/a000593.
9
Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
Value Health. 2014 Mar;17(2):223-30. doi: 10.1016/j.jval.2013.12.010.
10
[Primary prevention of cardiovascular disease with statin in type 2 diabetes mellitus: Is it time to change our strategy?].
Med Clin (Barc). 2014 Apr 22;142(8):358-9. doi: 10.1016/j.medcli.2014.01.003. Epub 2014 Mar 3.
引用本文的文献
1
A population-level study examining discontinuation of statins in older people with dementia.
Eur J Clin Pharmacol. 2018 Mar;74(3):379-381. doi: 10.1007/s00228-017-2390-4. Epub 2017 Dec 1.
Zotero 插件